ICCC
Immucell
$10.62
+$0.36 (+3.51%)Oct 28, 2026
Key metrics
The numbers that frame ICCC today
- Market cap
- $96.45M
- P/E (TTM)
- 151.7
- EV / FCF
- 23.6
- Gross margin
- 40.3%
- EV / Sales
- 3.3
- ROIC
- 1.8%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $4.52
- 52wk High
- $12.10
Growth
Revenue and earnings trend for ICCC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ICCC
Is Immucell a good buy?
Yes. Immucell has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Immucell is selling at a fair price.
What is the market capitalization of ICCC?
Immucell's market capitalization is $96.45M.
What is the P/E (TTM) ratio for ICCC stock?
Immucell's P/E (TTM) ratio is 151.7, based on trailing earnings.
What is the 52-week high for ICCC stock?
The 52-week high for Immucell is $12.10. The current close of $10.62 is 12.2% below that high.
What is the 52-week low for ICCC stock?
The 52-week low for Immucell is $4.52. The current close of $10.62 is 135% above that low.
Does ICCC stock pay dividends?
Immucell does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ICCC?
Immucell's Debt / Equity ratio is 0.4.